C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 249/08 (2006.01) A61K 31/4196 (2006.01) A61K 31/4245 (2006.01) A61P 3/10 (2006.01) C07D 401/04 (2006.01) C07D 403/04 (2006.01) C07D 403/08 (2006.01) C07D 405/04 (2006.01) C07D 407/04 (2006.01) C07D 409/04 (2006.01) C07D 413/08 (2006.01) C07D 417/08 (2006.01)
Patent
CA 2510540
Triazole derivatives of structural formula (I) are selective inhibitors of the 11.beta.-hydroxysteroid dehydrogenase-1. The compounds are useful for the treatment of diabetes, such as noninsulin-dependent diabetes (NIDDM), hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other symptoms associated with NIDDM.
L'invention concerne des dérivés de triazole de formule structurelle (I) qui sont des inhibiteurs sélecteurs de la 11.beta.-hydroxystéroïde déhydrogénase 1. Les composés sont utilisés dans le traitement de diabètes, tels que des diabètes non insulino dépendant (DNID), l'hyperglycémie, l'obésité, la résistance à l'insuline, la dyslipidémie, l'hyperlipidémie, l'hypertension, le syndrome métabolique et d'autres symptômes liés aux diabètes non insulino dépendant (DNID).
Aster Susan D.
Balkovec James M.
Graham Donald W.
Gu Xin
Leeman Aaron H.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Triazole derivatives as inhibitors of 11-beta-hydroxysteroid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole derivatives as inhibitors of 11-beta-hydroxysteroid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole derivatives as inhibitors of 11-beta-hydroxysteroid... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1892368